Cell Mol Life Sci. 2008 Mar;65(6):940-52.

Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives.

Source

Swiss HPB Center, Department of Visceral and Transplant Surgery, University Hospital of Zurich, Rämistrasse 100, Zürich, Switzerland.

Abstract

Beside its role as a neurotransmitter in the central nervous system, serotonin appears to be a central physiologic mediator of many gastrointestinal (GI) functions and a mediator of the brain-gut connection. By acting directly and via modulation of the enteric nervous system, serotonin has numerous effects on the GI tract. The main gut disturbances in which serotonin is involved are acute chemotherapy-induced nausea and vomiting, carcinoid syndrome and irritable bowel syndrome. Serotonin also has mitogenic properties. Platelet-derived serotonin is involved in liver regeneration after partial hepatectomy. In diseased liver, serotonin may play a crucial role in the progression of hepatic fibrosis and the pathogenesis of steatohepatitis. Better understanding of the role of the serotonin receptor subtypes and serotonin mechanisms of action in the liver and gut may open new therapeutic strategies in hepato-gastrointestinal diseases.

PMID:: 18080089; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Serotonin pharmacology in the gastrointestinal tract: a review. [Naunyn Schmiedebergs Arch Phar...]
Review Serotonin pharmacology in the gastrointestinal tract: a review.
Beattie DT, Smith JA. Naunyn Schmiedebergs Arch Pharmacol. 2008 May; 377(3):181-203. Epub 2008 Apr 9.
Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract. [J Pharmacol Exp Ther. 2008]
Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.
Liu Q, Yang Q, Sun W, Vogel P, Heydorn W, Yu XQ, Hu Z, Yu W, Jonas B, Pineda R, et al. J Pharmacol Exp Ther. 2008 Apr; 325(1):47-55. Epub 2008 Jan 11.
Review Role of serotonin in gastrointestinal motility and irritable bowel syndrome. [Clin Chim Acta. 2009]
Review Role of serotonin in gastrointestinal motility and irritable bowel syndrome.
Sikander A, Rana SV, Prasad KK. Clin Chim Acta. 2009 May; 403(1-2):47-55. Epub 2009 Feb 4.
Review Role of serotonin in gastrointestinal physiology and pathology. [Minerva Endocrinol. 2011]
Review Role of serotonin in gastrointestinal physiology and pathology.
Cirillo C, Vanden Berghe P, Tack J. Minerva Endocrinol. 2011 Dec; 36(4):311-24.
Review Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. [J Toxicol Sci. 2007]
Review Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
Nagata K, Suzuki H, Sakaguchi S. J Toxicol Sci. 2007 Dec; 32(5):453-68.

See reviews... See all...

Cited by 10 PubMed Central articles

HTR1A a Novel Type 1 Diabetes Susceptibility Gene on Chromosome 5p13-q13. [PLoS One. 2012]
HTR1A a Novel Type 1 Diabetes Susceptibility Gene on Chromosome 5p13-q13.
Asad S, Nikamo P, Gyllenberg A, Bennet H, Hansson O, Wierup N, Diabetes Incidence in Sweden Study Group, Carlsson A, Forsander G, Ivarsson SA, et al. PLoS One. 2012; 7(5):e35439. Epub 2012 May 1.
Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. [Front Psychol. 2012]
Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.
Andrews PW, Thomson JA Jr, Amstadter A, Neale MC. Front Psychol. 2012; 3:117. Epub 2012 Apr 24.
L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin. [J Biol Chem. 2011]
L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin.
Osawa Y, Kanamori H, Seki E, Hoshi M, Ohtaki H, Yasuda Y, Ito H, Suetsugu A, Nagaki M, Moriwaki H, et al. J Biol Chem. 2011 Oct 7; 286(40):34800-8. Epub 2011 Aug 12.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new ...
Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives.
Cell Mol Life Sci. 2008 Mar ;65(6):940-52.

PubMed
Suppressive effect by melatonin on different phases of 9,10-dimethyl-1,2-benzant...
Suppressive effect by melatonin on different phases of 9,10-dimethyl-1,2-benzanthracene (DMBA)-induced rat mammary gland carcinogenesis.
Anticancer Drugs. 1991 Jun ;2(3):297-303.

PubMed
BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a c...
BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy.
Cancer Epidemiol Biomarkers Prev. 2007 Nov ;16(11):2276-84.

PubMed
Proteinases of the mammary gland: developmental regulation in vivo and vectorial...
Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture.
Development. 1991 Jun ;112(2):439-49.

PubMed
The unfolded protein response regulator GRP78/BiP as a novel target for increasi...
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
Cancer Res. 2007 Oct 15 ;67(20):9809-16.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: